Business
Pfizer to seek vaccine approval in November – Bangkok Post
WASHINGTON” The US pharmaceutical giant Pfizer expects to file for emergency use authorisation for its Covid-19 vaccine in late November, around two weeks after…
WASHINGTON” The US pharmaceutical giant Pfizer expects to file for emergency use authorisation for its Covid-19 vaccine in late November, around two weeks after the Nov 3 US presidential election, it said on Friday.
The company said it hopes to move ahead with the vaccine after safety data is available in the third week of November, immediately lifting the company’s shares two percent in the US.
“So let me be clear, assuming positive data, Pfizer will apply for Emergency Authorisation Use in t…
-
Noosa News23 hours agoElderly driver killed in crash on Mount Coot-tha
-
General22 hours agoSmall team of rowers from Perth represents Australia on world skiffie stage
-
Business24 hours agoEnergy shares rip amid Middle East tensions while ASX 200 surges 20% from April low
-
Business24 hours agoTop brokers name 3 ASX shares to buy next week 15 June 2025